Evaluation of a TNFR2 antibody with and without anti-PD-1 therapy in two murine colon cancer models

被引：0
|
作者：
Case, Katie [1 ]
Tran, Lisa [1 ]
Zheng, Hui [1 ]
Yang, Michael [1 ]
Faustman, Denise [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Charlestown, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P479
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models
    Case, Katherine
    Tran, Lisa
    Yang, Michael
    Zheng, Hui
    Kuhtreiber, Willem M.
    Faustman, Denise L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 107 (06) : 981 - 991
  • [2] TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models.
    LaMontagne, Russell
    Case, Katie
    Tran, Lisa
    Zheng, Hui
    Yang, Michael
    Faustman, Denise
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 124 - 125
  • [3] Agranulocytosis under Anti-PD-1 Antibody Therapy
    Gellrich, F. F.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 78 - 79
  • [4] A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer
    Jiang, Mengmeng
    Liu, Jia
    Yang, De
    Tross, Debra
    Li, Ping
    Chen, Fengyang
    Alam, Md Masud
    Faustman, Denise L.
    Oppenheim, Joost J.
    Chen, Xin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [5] Anti-PD-1 monoclonal antibody Cancer immunotherapy
    da Silva, R. Moreira
    DRUGS OF THE FUTURE, 2014, 39 (01) : 15 - 24
  • [6] Anti-PD-1 Antibody Treatment Suppresses Endometriosis in a Murine Model
    Mamillapalli, Ramanaiah
    Habata, Shutaro
    Taylor, Hugh S.
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 202 - 202
  • [7] ASSESSMENT OF ANTI-CD69 ANTIBODY THERAPY ALONE OR IN COMBINATION WITH ANTI-PD-1 IN MURINE GBM
    Nisnboym Ziv, Michal
    Kohanbash, Gary
    Raphael, Itay
    NEURO-ONCOLOGY, 2024, 26
  • [8] Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBM
    Nisnboym, Michal
    Sneiderman, Chaim T.
    Jaswal, Ambika P.
    Xiong, Zujian
    Vincze, Sarah R.
    Sever, ReidAnn E.
    Zou, Han
    Frederico, Stephen C.
    Agnihotri, Sameer
    Hu, Baoli
    Drappatz, Jan
    Pollack, Ian F.
    Kohanbash, Gary
    Raphael, Itay
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2025, 21 (02) : 239 - 247
  • [9] Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
    Su, Xin
    Li, Jian
    Xu, Xiao
    Ye, Youbao
    Wang, Cailiu
    Pang, Guanglong
    Liu, Wenxiu
    Liu, Ang
    Zhao, Changchun
    Hao, Xiangyong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [10] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Hiro Sato
    Noriyuki Okonogi
    Takashi Nakano
    International Journal of Clinical Oncology, 2020, 25 : 801 - 809
12345